Accelrys' Q1 Revenues Rise 7 Percent but Fall Short of Estimates

May 01, 2013

|

NEW YORK (GenomeWeb News) – Accelrys said after the close of the market on Tuesday that its first-quarter revenues were up 7 percent year over year.

Total revenues for the three months ended March 31 were $42.1 million, compared to $39.4 million for the first quarter a year ago, short of the average Wall Street estimate of $45.4 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Jun

12

Featured Webinar

Bridging the Gap Between Testing and Treatment in Precision Oncology

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Main menu